Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy.

[1]  Yoosoo Chang,et al.  Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non‐alcoholic fatty liver disease , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[2]  F. Hu,et al.  Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. , 2019, The lancet. Diabetes & endocrinology.

[3]  Peng Zhang,et al.  Metabolic Features of Individuals with Obesity Referred for Bariatric and Metabolic Surgery: a Cohort Study , 2019, Obesity Surgery.

[4]  R. Andrade,et al.  The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity , 2018, Alimentary pharmacology & therapeutics.

[5]  B. Neuschwander‐Tetri,et al.  Mechanisms of NAFLD development and therapeutic strategies , 2018, Nature Medicine.

[6]  X. García-Moll.  Obesity and prognosis: Time to forget about metabolically healthy obesity , 2018, European heart journal.

[7]  P. Schauer,et al.  Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[8]  S. Sarin,et al.  Non‐alcoholic fatty liver disease – histological scoring systems: a large cohort single‐center, evaluation study , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[9]  F. Schick,et al.  Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. , 2017, Cell metabolism.

[10]  R. Lima,et al.  "Metabolically healthy" obesity: Prevalence, clinical features and association with myocardial ischaemia. , 2017, Obesity research & clinical practice.

[11]  E. Benjamin,et al.  Relations of Metabolically Healthy and Unhealthy Obesity to Digital Vascular Function in Three Community‐Based Cohorts: A Meta‐Analysis , 2017, Journal of the American Heart Association.

[12]  C. Phillips.  Metabolically healthy obesity across the life course: epidemiology, determinants, and implications , 2017, Annals of the New York Academy of Sciences.

[13]  A. Fernández-Montero,et al.  Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort , 2017, International journal of stroke : official journal of the International Stroke Society.

[14]  S. Bellentani.  The epidemiology of non‐alcoholic fatty liver disease , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Yimin Zhu,et al.  The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis , 2016, Journal of Epidemiology & Community Health.

[16]  E. Guallar,et al.  Metabolically Healthy Obesity and Development of Chronic Kidney Disease , 2016, Annals of Internal Medicine.

[17]  M. Calvani,et al.  New obesity classification criteria as a tool for bariatric surgery indication. , 2016, World journal of gastroenterology.

[18]  M. Kivimäki,et al.  Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. , 2015, European journal of endocrinology.

[19]  F. Pattou,et al.  Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. , 2015, Gastroenterology.

[20]  A. Burt,et al.  Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. , 2015, Journal of hepatology.

[21]  S. Brethauer,et al.  Standardized outcomes reporting in metabolic and bariatric surgery. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[22]  Zhen Wang,et al.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  M. Kivimaki,et al.  The natural course of healthy obesity over 20 years. , 2015, Journal of the American College of Cardiology.

[24]  F. Pattou,et al.  Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease: A 5-Year Controlled Longitudinal Study , 2014, Annals of surgery.

[25]  F. Tacke,et al.  Roles for chemokines in liver disease. , 2014, Gastroenterology.

[26]  C. Apovian,et al.  Metabolically Healthy Obesity—Does it Exist? , 2014, Current Atherosclerosis Reports.

[27]  M. Kivimaki,et al.  Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies , 2014, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[28]  B. Zinman,et al.  Are Metabolically Healthy Overweight and Obesity Benign Conditions? , 2013, Annals of Internal Medicine.

[29]  P. Bedossa,et al.  A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. , 2013, Journal of hepatology.

[30]  Joan Tordjman,et al.  Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients , 2012, Hepatology.

[31]  K. Clément,et al.  C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. , 2011, Journal of hepatology.

[32]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[33]  R. Sladek,et al.  Characterizing the profile of obese patients who are metabolically healthy , 2011, International Journal of Obesity.

[34]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[35]  N. Luciani,et al.  The Inflammatory C-Reactive Protein is Increased in Both Liver and Adipose Tissue in Severely Obese Patients Independently from Metabolic Syndrome, Type 2 Diabetes, and NASH , 2006, The American Journal of Gastroenterology.

[36]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[37]  C. Mottin,et al.  A Comparison of Wedge and Needle Hepatic Biopsy in Open Bariatric Surgery , 2006, Obesity surgery.

[38]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[39]  Jeanne M Clark,et al.  Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[40]  J. Gugenheim,et al.  Bariatric Surgery and Liver Transplantation: a Systematic Review a New Frontier for Bariatric Surgery , 2014, Obesity Surgery.